BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.84B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
NVIDIA
NVDA
|
+$1.94B |
| 4 |
Amazon
AMZN
|
+$1.5B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.61B |
| 2 |
Merck
MRK
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$309M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$227M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.57% |
| 2 | Consumer Discretionary | 8.06% |
| 3 | Financials | 7.49% |
| 4 | Healthcare | 6.58% |
| 5 | Communication Services | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Monopar Therapeutics
MNPR
$759M
| $66.3K | ﹤0.01% |
1,015
+319
| +46% | +$26.1K |
|
|
LENZ
4402
LENZ Therapeutics
LENZ
$149M
| $66.2K | ﹤0.01% |
4,135
+613
| +17% | +$17.9K |
|
4403
TFS Financial
TFSL
$4.95B
| $66.1K | ﹤0.01% |
4,939
-18,199
| -79% | -$249K |
|
4404
Genie Energy
GNE
$383M
| $66.1K | ﹤0.01% |
4,795
+477
| +11% | +$7.02K |
|
|
KALV
4405
DELISTED
KalVista Pharmaceuticals
KALV
| $66.1K | ﹤0.01% |
4,090
-3,704
| -48% | -$49.1K |
|
4406
MVB Financial
MVBF
$398M
| $66K | ﹤0.01% |
2,555
-688
| -21% | -$18.3K |
|
|
SZZLR
4407
Sizzle Acquisition Corp II Right
SZZLR
| $65.9K | ﹤0.01% |
+411,978
| New | +$86.7K |
|
4408
LCNB Corp
LCNB
$283M
| $65.9K | ﹤0.01% |
4,019
+417
| +12% | +$6.56K |
|
|
KWY
4409
Kingsway Corp
KWY
$285M
| $65.8K | ﹤0.01% |
4,890
+749
| +18% | +$10.3K |
|
4410
Blue Ridge Bankshares
BRBS
$331M
| $65.7K | ﹤0.01% |
15,377
-634
| -4% | -$2.75K |
|
4411
Limoneira
LMNR
$251M
| $65.3K | ﹤0.01% |
5,170
+1,869
| +57% | +$26.4K |
|
4412
NVE Corp
NVEC
$587M
| $65.1K | ﹤0.01% |
1,098
-5
| -0.5% | -$334 |
|
4413
Delcath Systems
DCTH
$581M
| $65K | ﹤0.01% |
6,437
+611
| +10% | +$6.07K |
|
4414
Omega Flex
OFLX
$289M
| $64.8K | ﹤0.01% |
2,201
-2,478
| -53% | -$70.7K |
|
4415
Aclaris Therapeutics
ACRS
$851M
| $64.8K | ﹤0.01% |
21,516
-5,151
| -19% | -$13K |
|
4416
Claros Mortgage Trust
CMTG
$257M
| $64.6K | ﹤0.01% |
21,113
+3,218
| +18% | +$10.5K |
|
|
SIMAW
4417
SIM Acquisition Corp I Warrant
SIMAW
$2.3M
| $64.5K | ﹤0.01% |
299,540
| – | – |
|
|
SVC
4418
Service Properties Trust
SVC
$1.05B
| $64.4K | ﹤0.01% |
7,004
+1,015
| +17% | +$10.2K |
|
4419
XBiotech
XBIT
$70.1M
| $64.2K | ﹤0.01% |
26,864
+6,254
| +30% | +$15.4K |
|
4420
Chemung Financial Corp
CHMG
$405M
| $63.3K | ﹤0.01% |
1,134
+50
| +5% | +$2.65K |
|
4421
SIGA Technologies
SIGA
$216M
| $63.2K | ﹤0.01% |
10,336
+1,295
| +14% | +$9.21K |
|
|
CIO
4422
DELISTED
City Office REIT
CIO
| $63K | ﹤0.01% |
9,017
-12,269
| -58% | -$84.9K |
|
4423
FS Bancorp
FSBW
$323M
| $62.2K | ﹤0.01% |
1,510
+180
| +14% | +$7.23K |
|
4424
Dorchester Minerals
DMLP
$1.36B
| $62K | ﹤0.01% |
2,771
+2,765
| +46,083% | +$64.7K |
|
4425
Spok Holdings
SPOK
$229M
| $61.8K | ﹤0.01% |
4,686
-13,715
| -75% | -$194K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2025 Portfolio in Review
As of Q4 2025, BNP Paribas Financial Markets held 6,035 positions worth $221B, up 18% from $187B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $25.1B of net new capital in Q4 2025, opening 491 new positions and adding to 2,632 existing holdings. Its largest new stake was Iris Energy: 4,201,138 shares worth $159M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.61B trimmed.
- BNP Paribas Financial Markets's largest Q4 2025 buy was Iris Energy: 4,201,138 shares worth $159M.
- BNP Paribas Financial Markets added most to Microsoft in Q4 2025, an estimated $2.84B increase.
- BNP Paribas Financial Markets's biggest Q4 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.61B.
- BNP Paribas Financial Markets fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $41M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $221B portfolio in Q4 2025.
- BNP Paribas Financial Markets opened 491 new positions and closed 305 in Q4 2025.
- BNP Paribas Financial Markets's portfolio value rose 18% quarter-over-quarter to $221B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.